Fenlean
Fenlean (FLZ) is a tyrosine kinase Src inhibitor, a synthetic cyclic derivative of squamous amide from Annona glabra, with cytoprotective activity, which protects tyrosine hydroxylase function in a chronic MPTP/prostaglandin-type mouse model of Parkinson's disease.Fenlean inhibits the production of Aβ in the mitochondria, which may be useful in the study of age-related macular degeneration and Parkinson's disease. and Parkinson's.
Product Specifications
CAS Number
863193-70-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.5
Molecular Formula
C26H27NO6
Notes
Research use only, not for human use.
Receptor
Beta Amyloid | Src
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1200845-01 0.02 mg (E-Coli)
Recombinant Serratia proteamaculans 4-alpha-L-fucosyltransferase (wecF)
Ask
View Details 
MBS1200845-02 0.02 mg (Yeast)
Recombinant Serratia proteamaculans 4-alpha-L-fucosyltransferase (wecF)
Ask
View Details MBS1200845-03 0.1 mg (E-Coli)
Recombinant Serratia proteamaculans 4-alpha-L-fucosyltransferase (wecF)
Ask
View Details MBS1200845-04 0.1 mg (Yeast)
Recombinant Serratia proteamaculans 4-alpha-L-fucosyltransferase (wecF)
Ask
View Details 
MBS1200845-05 0.02 mg (Baculovirus)
Recombinant Serratia proteamaculans 4-alpha-L-fucosyltransferase (wecF)
Ask
View Details 
MBS1200845-06 0.02 mg (Mammalian-Cell)
Recombinant Serratia proteamaculans 4-alpha-L-fucosyltransferase (wecF)
Ask
View Details